Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

A Study of the Use of Text Message Reminders to Take Palbociclib

Summary

The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance)
>/= 18 years of age
Able to speak, read and write English
Willingness and ability to send and receive text messages with intervention app
Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application
Criteria applicable for both Control and Intervention groups
Flip-phones do not support OhMD Application and thus ineligible to participate
Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)

Exclusion Criteria:

History of taking palbociclib (Ibrance)
Patients whose caregivers coordinate their health care

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info